Expanding the surveillance for the gonococcal resistance

Citation metadata

Date: April-June 2016
From: Community Acquired Infection(Vol. 3, Issue 2)
Publisher: Medknow Publications and Media Pvt. Ltd.
Document Type: Letter to the editor; Report
Length: 725 words
Lexile Measure: 3270L

Document controls

Main content

Article Preview :

Byline: Saurabh. Shrivastava, Prateek. Shrivastava, Jegadeesh. Ramasamy

Dear Editor,

Sexually transmitted infections (STIs) tend to cast a major influence on not only the sexual and reproductive health but also the overall living standards and have been identified as one of the five major disease categories necessitating adults to access healthcare services. [sup][1] The recent global estimates suggest that more than 1 million people get infected with one of the STIs every day while almost 500 million people annually acquire the infection from one of the four major STIs, including gonorrhea. [sup][1]

Evidence of antibiotic resistance against majority of the STIs has appeared; the scenario is extremely complex for the management of gonorrhea. [sup][2] Further, reports of multi-drug resistant gonorrhea (namely, the microorganism being resistant to oral and injectable cephalosporins, penicillins, sulfonamides, tetracyclines, quinolones, and macrolides) have been reported in more than thirty nations across the world. [sup][1],[2] This is a serious challenge for the health professionals, as a disease which could have been easily cured with a single dose of antibiotic might now eventually precipitate severe complications such as infertility, blindness...

Source Citation

Source Citation   

Gale Document Number: GALE|A457073617